Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments

Coronavirus disease 2019 (COVID-19)-related stressors and restrictions, in the absence of social and institutional support, have led many individuals to either increase their substance consumption or relapse. Consequently, treatment programs for substance use disorders (SUDs) made a transition from...

Descripción completa

Detalles Bibliográficos
Autores principales: Melamed, Osnat C., deRuiter, Wayne K., Buckley, Leslie, Selby, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585604/
https://www.ncbi.nlm.nih.gov/pubmed/35219445
http://dx.doi.org/10.1016/j.psc.2021.11.006
_version_ 1784597726011326464
author Melamed, Osnat C.
deRuiter, Wayne K.
Buckley, Leslie
Selby, Peter
author_facet Melamed, Osnat C.
deRuiter, Wayne K.
Buckley, Leslie
Selby, Peter
author_sort Melamed, Osnat C.
collection PubMed
description Coronavirus disease 2019 (COVID-19)-related stressors and restrictions, in the absence of social and institutional support, have led many individuals to either increase their substance consumption or relapse. Consequently, treatment programs for substance use disorders (SUDs) made a transition from in-person to remote care delivery. This review discusses the following evidence regarding changes prompted by the COVID pandemic to the clinical care of individuals with SUDs: (1) reduction in availability of care, (2) increase in demand for care, (3) transition to telemedicine use, (4) telemedicine for treatment of opioid use disorders, and (5) considerations for use of telemedicine in treating SUDs.
format Online
Article
Text
id pubmed-8585604
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-85856042021-11-12 Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments Melamed, Osnat C. deRuiter, Wayne K. Buckley, Leslie Selby, Peter Psychiatr Clin North Am Article Coronavirus disease 2019 (COVID-19)-related stressors and restrictions, in the absence of social and institutional support, have led many individuals to either increase their substance consumption or relapse. Consequently, treatment programs for substance use disorders (SUDs) made a transition from in-person to remote care delivery. This review discusses the following evidence regarding changes prompted by the COVID pandemic to the clinical care of individuals with SUDs: (1) reduction in availability of care, (2) increase in demand for care, (3) transition to telemedicine use, (4) telemedicine for treatment of opioid use disorders, and (5) considerations for use of telemedicine in treating SUDs. Published by Elsevier Inc. 2022-03 2021-11-12 /pmc/articles/PMC8585604/ /pubmed/35219445 http://dx.doi.org/10.1016/j.psc.2021.11.006 Text en Crown Copyright © 2021 Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Melamed, Osnat C.
deRuiter, Wayne K.
Buckley, Leslie
Selby, Peter
Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments
title Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments
title_full Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments
title_fullStr Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments
title_full_unstemmed Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments
title_short Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments
title_sort coronavirus disease 2019 and the impact on substance use disorder treatments
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585604/
https://www.ncbi.nlm.nih.gov/pubmed/35219445
http://dx.doi.org/10.1016/j.psc.2021.11.006
work_keys_str_mv AT melamedosnatc coronavirusdisease2019andtheimpactonsubstanceusedisordertreatments
AT deruiterwaynek coronavirusdisease2019andtheimpactonsubstanceusedisordertreatments
AT buckleyleslie coronavirusdisease2019andtheimpactonsubstanceusedisordertreatments
AT selbypeter coronavirusdisease2019andtheimpactonsubstanceusedisordertreatments

Ejemplares similares